Prioritisation of potential drug targets against Bartonella bacilliformis by an integrative in-silico approach.

CONCLUSION This work represents an effort to reduce the costs in the first phases of B. bacilliformis drug discovery. PMID: 32785422 [PubMed - in process]
Source: Memorias do Instituto Oswaldo Cruz - Category: Infectious Diseases Authors: Tags: Mem Inst Oswaldo Cruz Source Type: research